The US Food and Drug Administration (FDA) has approved Boston Scientific’s Vercise Deep Brain Stimulation (DBS) System for the treatment of Parkinson’s disease symptoms.
A DBS system is designed to trigger a targeted region of the brain through implanted leads powered by a device called implantable pulse generator (IPG).
The small, rechargeable Vercise system features a capability to independently regulate the amount of current to be delivered by each electrode on the implanted leads.
